Jaume Barallat

1.7k total citations
32 papers, 1.1k citations indexed

About

Jaume Barallat is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jaume Barallat has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 5 papers in Molecular Biology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jaume Barallat's work include Heart Failure Treatment and Management (14 papers), Cardiovascular Function and Risk Factors (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Jaume Barallat is often cited by papers focused on Heart Failure Treatment and Management (14 papers), Cardiovascular Function and Risk Factors (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Jaume Barallat collaborates with scholars based in Spain, United States and Singapore. Jaume Barallat's co-authors include Antoni Bayés‐Genís, Josep Lupón, Amparo Galán, Mark Richards, Elisabet Zamora, Marta de Antonio, Agustín Urrútia, Mar Domingo, Judith Peñafiel and Joan Vila and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Analytical Chemistry.

In The Last Decade

Jaume Barallat

32 papers receiving 1.1k citations

Peers

Countries citing papers authored by Jaume Barallat

Since Specialization

Citations

This map shows the geographic impact of Jaume Barallat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaume Barallat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaume Barallat more than expected).

Fields of papers citing papers by Jaume Barallat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaume Barallat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaume Barallat. The network helps show where Jaume Barallat may publish in the future.

Co-authorship network of co-authors of Jaume Barallat

This figure shows the co-authorship network connecting the top 25 collaborators of Jaume Barallat. A scholar is included among the top collaborators of Jaume Barallat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaume Barallat. Jaume Barallat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A multiplexed immunochemical microarray for the determination of cardiovascular disease biomarkers 2023 ·Microchimica Acta ·(unknown), (unknown), Jaume Barallat, Amparo Galán, Antoni Bayés‐Genís, J.‐Pablo Salvador, M.‐Pilar Marco	3
2	Analytical Performance of Quantitative DiaSorin Liaison SARS-COV-2 Antigen Test for the Asymptomatic Population 2022 ·Frontiers in Public Health ·Gema Fernández‐Rivas, Jaume Barallat, Victoria González, (unknown), Antoni E. Bordoy, Laura Jiménez, Cristina Casañ, Ignacio Blanco	4
3	Finding a reliable assay for soluble neprilysin 2022 ·Clinical Biochemistry ·Oi Wah Liew, Timothy C. R. Prickett, Elena Revuelta‐López, Samantha Shi Min Ling, (unknown), Josep Lupón, Jessica Yan Xia Ng, Jenny Chong, (unknown), Siew‐Pang Chan, Qifeng Lin, Teck Kwang Lim, Qingsong Lin, Jaume Barallat, Antoni Bayés‐Genís, Mark Richards	2
4	Elevated Neopterin Levels Predict Fatal Outcome in SARS-CoV-2-Infected Patients 2021 ·Frontiers in Cellular and Infection Microbiology ·(unknown), Martin Larsen, Bibiana Quirant‐Sánchez, Paul Quentric, Karim Dorgham, (unknown), Hélène Vallet, Amélie Guihot, Béhazine Combadière, Christophe Combadière, Jaume Barallat, Julien Mayaux, Charles‐Édouard Luyt, Alexis Mathian, Zahir Amoura, Jacques Boddaert, Fernándo Arméstar, Guy Gorochov, Eva Martínez‐Cáceres, Delphine Sauce	16
5	The influence of sex and body mass index on the association between soluble neprilysin and risk of heart failure hospitalizations 2021 ·Scientific Reports ·Julio Núñez, Eduardo Núñez, Elena Revuelta‐López, Gema Miñana, Jaume Barallat, Vicent Bodı́, Juan Sanchís, Alberto Aimo, Michele Emdin, Josep Lupón, Oliver Hüsser, Antoni Bayés‐Genís	2
6	Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave 2020 ·PLoS ONE ·Jaume Barallat, Gema Fernández‐Rivas, Bibiana Quirant‐Sánchez, Victoria González, María Doladé, Eva Martínez‐Cáceres, (unknown), (unknown), Oriol Estrada, Ignacio Blanco	26
7	Clinical Role of CA125 in Worsening Heart Failure 2020 ·JACC Heart Failure ·Julio Núñez, Antoni Bayés‐Genís, Elena Revuelta‐López, Jozine M. ter Maaten, Gema Miñana, Jaume Barallat, (unknown), Vicent Bodı́, Agustín Fernández‐Cisnal, Eduardo Núñez, Juan Sanchís, Chim C. Lang, Leong L. Ng, Marco Metra, Adriaan A. Voors	77
8	Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction 2018 ·International Journal of Cardiology ·Pedro Moliner, Josep Lupón, Jaume Barallat, Marta de Antonio, Mar Domingo, Julio Núñez, Elisabet Zamora, Amparo Galán, Javier Santesmases, (unknown), Antoni Bayés‐Genís	36
9	Predictive biomarkers for death and rehospitalization in comorbid frail elderly heart failure patients 2018 ·BMC Geriatrics ·Cristina Pacho, Mar Domingo, (unknown), Josep Lupón, Julio Núñez, Jaume Barallat, Pedro Moliner, Marta de Antonio, Javier Santesmases, Germán Cediel, Santiago Roura, M.C. Pastor, Jordi Tor, Antoni Bayés‐Genís	33
10	Bloodstream Amyloid-beta (1-40) Peptide, Cognition, and Outcomes in Heart Failure 2017 ·Revista Española de Cardiología (English Edition) ·Antoni Bayés‐Genís, Jaume Barallat, Marta de Antonio, Mar Domingo, Elisabet Zamora, Joan Vila, Isaac Subirana, Paloma Gastelurrutia, M.C. Pastor, James L. Januzzi, Josep Lupón	20
11	Inflammation and oxidation: do they improve after kidney transplantation? Relationship with mortality after transplantation 2016 ·International Urology and Nephrology ·(unknown), Eva Iglesias, M.C. Pastor, Jaume Barallat, Javier Juega, Ioana Bancu, Ricardo Lauzurica	7
12	Impact of diabetes on the predictive value of heart failure biomarkers 2016 ·Cardiovascular Diabetology ·Núria Alonso, Josep Lupón, Jaume Barallat, Marta de Antonio, Mar Domingo, Elisabet Zamora, Pedro Moliner, Amparo Galán, Javier Santesmases, (unknown), Dı́dac Mauricio, Antoni Bayés‐Genís	48
13	A Test in Context: Neprilysin 2016 ·Journal of the American College of Cardiology ·Antoni Bayés‐Genís, Jaume Barallat, Mark Richards	175
14	Soluble Neprilysin Is Predictive of Cardiovascular Death and Heart Failure Hospitalization in Heart Failure Patients 2015 ·Journal of the American College of Cardiology ·Antoni Bayés‐Genís, Jaume Barallat, Amparo Galán, Marta de Antonio, Mar Domingo, Elisabet Zamora, Agustín Urrútia, Josep Lupón	120
15	Sodium interference in the determination of urinary aldosterone 2015 ·Clinical Biochemistry ·(unknown), Jaume Barallat, (unknown), (unknown), M.C. Pastor, María Luisa Granada	6
16	Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP 2015 ·Revista Española de Cardiología (English Edition) ·Antoni Bayés‐Genís, Jaume Barallat, Amparo Galán, Marta de Antonio, Mar Domingo, Elisabet Zamora, Paloma Gastelurrutia, Joan Vila, Judith Peñafiel, Carolina Gálvez‐Montón, Josep Lupón	27
17	Dual chronoamperometric detection of enzymatic biomarkers using magnetic beads and a low-cost flow cell 2015 ·Biosensors and Bioelectronics ·Javier Moral‐Vico, Jaume Barallat, Llibertat Abad, (unknown), Francesc Xavier Muñoz, (unknown), F. Javier del Campo, Eva Baldrich	26
18	Prognostic Value and Kinetics of Soluble Neprilysin in Acute Heart Failure 2015 ·JACC Heart Failure ·Antoni Bayés‐Genís, Jaume Barallat, Domingo A. Pascual‐Figal, Julio Núñez, Gema Miñana, Jesús Sánchez‐Más, Amparo Galán, Juan Sanchis, Elisabet Zamora, (unknown), Josep Lupón	36
19	Head-to-Head Comparison of 2 Myocardial Fibrosis Biomarkers for Long-Term Heart Failure Risk Stratification 2013 ·Journal of the American College of Cardiology ·Antoni Bayés‐Genís, Marta de Antonio, Joan Vila, Judith Peñafiel, Amparo Galán, Jaume Barallat, Elisabet Zamora, Agustín Urrútia, Josep Lupón	208
20	Biological Signatures of Asymptomatic Extra- and Intracranial Atherosclerosis 2012 ·Stroke ·Elena López‐Cancio, Amparo Galán, Laura Dorado, Marta Jiménez, María Catalina Hernández‐Rodas, Mónica Millán, Sílvia Reverté‐Villarroya, Anna Suñol, Jaume Barallat, Anna Massuet, María Teresa Alzamora, Antonio Dávalos, Juan F. Arenillas	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact